PL2569417T3 - Izolowane populacje dorosłych komórek nerkowych i sposoby ich izolowania i stosowania - Google Patents

Izolowane populacje dorosłych komórek nerkowych i sposoby ich izolowania i stosowania

Info

Publication number
PL2569417T3
PL2569417T3 PL11728406T PL11728406T PL2569417T3 PL 2569417 T3 PL2569417 T3 PL 2569417T3 PL 11728406 T PL11728406 T PL 11728406T PL 11728406 T PL11728406 T PL 11728406T PL 2569417 T3 PL2569417 T3 PL 2569417T3
Authority
PL
Poland
Prior art keywords
isolating
methods
same
renal cells
isolated populations
Prior art date
Application number
PL11728406T
Other languages
English (en)
Inventor
Benjamin Dekel
Orit Harari-Steinberg
Ella Buzhor
Original Assignee
Tel Hashomer Medical Research Infrastructure And Services Ltd.
Ramot At Tel-Aviv University Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tel Hashomer Medical Research Infrastructure And Services Ltd., Ramot At Tel-Aviv University Ltd. filed Critical Tel Hashomer Medical Research Infrastructure And Services Ltd.
Publication of PL2569417T3 publication Critical patent/PL2569417T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0684Cells of the urinary tract or kidneys
    • C12N5/0686Kidney cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/90Serum-free medium, which may still contain naturally-sourced components
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/11Epidermal growth factor [EGF]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/115Basic fibroblast growth factor (bFGF, FGF-2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30Hormones
    • C12N2501/33Insulin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30Hormones
    • C12N2501/38Hormones with nuclear receptors
    • C12N2501/39Steroid hormones
    • C12N2501/392Sexual steroids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00Supports or coatings for cell culture, characterised by material
    • C12N2533/30Synthetic polymers
    • C12N2533/40Polyhydroxyacids, e.g. polymers of glycolic or lactic acid (PGA, PLA, PLGA); Bioresorbable polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL11728406T 2010-05-13 2011-05-12 Izolowane populacje dorosłych komórek nerkowych i sposoby ich izolowania i stosowania PL2569417T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US33420610P 2010-05-13 2010-05-13
US201161457613P 2011-05-02 2011-05-02
EP11728406.7A EP2569417B1 (en) 2010-05-13 2011-05-12 Isolated populations of adult renal cells and methods of isolating and using same
PCT/IL2011/000376 WO2011141914A1 (en) 2010-05-13 2011-05-12 Isolated populations of adult renal cells and methods of isolating and using same

Publications (1)

Publication Number Publication Date
PL2569417T3 true PL2569417T3 (pl) 2018-12-31

Family

ID=44515147

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11728406T PL2569417T3 (pl) 2010-05-13 2011-05-12 Izolowane populacje dorosłych komórek nerkowych i sposoby ich izolowania i stosowania

Country Status (6)

Country Link
US (2) US20130059325A1 (pl)
EP (1) EP2569417B1 (pl)
CA (1) CA2799307C (pl)
ES (1) ES2672918T3 (pl)
PL (1) PL2569417T3 (pl)
WO (1) WO2011141914A1 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010097794A1 (en) 2009-02-26 2010-09-02 Tel Hashomer Medical Research Infrastructure And Services Ltd. Methods of reprogramming renal cells
AU2014280843B2 (en) 2013-06-14 2017-04-20 The University Of Queensland Renal progenitor cells
WO2015134610A1 (en) * 2014-03-06 2015-09-11 Yale University Methods for treating diabetic nephropathy
CN108348554B (zh) * 2015-09-03 2021-11-09 布里格姆及妇女医院股份有限公司 上胚层球状体向肾脏类器官的三维分化模拟阶段特异性上皮生理、形态发生和疾病
US11268950B2 (en) 2016-09-28 2022-03-08 Organovo, Inc. Use of engineered renal tissues in assays
WO2018186185A1 (ja) 2017-04-06 2018-10-11 日機装株式会社 細胞の培養方法、細胞支持複合体の製造方法、培養細胞及び細胞支持複合体
EP3770248A4 (en) 2018-03-22 2022-01-19 Nikkiso Co., Ltd. Cell culturing method, method for producing cell support composite, cultured cell, and cell support composite
CN114390925A (zh) * 2019-05-02 2022-04-22 蒂莫西.伯特伦 治疗具有肾脏和/或尿路异常的受试者的肾病
WO2022084998A1 (en) * 2020-10-19 2022-04-28 Tel Hashomer Medical Research Infrastructure And Services Ltd. Urine-derived epithelial cell cultures, nephrospheroids derived therefrom and methods of producing and using same

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154600B (nl) 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
NL154599B (nl) 1970-12-28 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
US3901654A (en) 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors
US3853987A (en) 1971-09-01 1974-12-10 W Dreyer Immunological reagent and radioimmuno assay
US3867517A (en) 1971-12-21 1975-02-18 Abbott Lab Direct radioimmunoassay for antigens and their antibodies
NL171930C (nl) 1972-05-11 1983-06-01 Akzo Nv Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
US3850578A (en) 1973-03-12 1974-11-26 H Mcconnell Process for assaying for biologically active molecules
US3935074A (en) 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4034074A (en) 1974-09-19 1977-07-05 The Board Of Trustees Of Leland Stanford Junior University Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US3984533A (en) 1975-11-13 1976-10-05 General Electric Company Electrophoretic method of detecting antigen-antibody reaction
US4098876A (en) 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
US4879219A (en) 1980-09-19 1989-11-07 General Hospital Corporation Immunoassay utilizing monoclonal high affinity IgM antibodies
US5011771A (en) 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US5281521A (en) 1992-07-20 1994-01-25 The Trustees Of The University Of Pennsylvania Modified avidin-biotin technique
US6150164A (en) 1996-09-30 2000-11-21 The Regents Of The University Of Michigan Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo
US6235551B1 (en) 1997-12-31 2001-05-22 Micron Technology, Inc. Semiconductor device including edge bond pads and methods
US6458588B1 (en) 2001-01-31 2002-10-01 The General Hospital Corporation Renal stem cells and uses thereof
US20040014209A1 (en) 2002-01-23 2004-01-22 Lassar Andrew B. Compositions and methods for modulating cell differentiation
JP2005050666A (ja) 2003-07-28 2005-02-24 Tokai Rubber Ind Ltd 燃料電池用ホース材料およびそれを用いてなる燃料電池用ホース
US20070031966A1 (en) 2005-07-18 2007-02-08 Regents Of The University Of Michigan Renal progenitor cells from embryonic stem cells
US7776592B2 (en) 2005-08-31 2010-08-17 Stc.Unm Human renal stem cells
TW200925513A (en) 2007-12-11 2009-06-16 Prodisc Technology Inc LED lamp structure for reducing multiple shadows
WO2010097794A1 (en) 2009-02-26 2010-09-02 Tel Hashomer Medical Research Infrastructure And Services Ltd. Methods of reprogramming renal cells

Also Published As

Publication number Publication date
CA2799307C (en) 2019-07-02
EP2569417B1 (en) 2018-04-18
US20130059325A1 (en) 2013-03-07
ES2672918T3 (es) 2018-06-18
WO2011141914A1 (en) 2011-11-17
US10870834B2 (en) 2020-12-22
CA2799307A1 (en) 2011-11-17
US20180346882A1 (en) 2018-12-06
EP2569417A1 (en) 2013-03-20

Similar Documents

Publication Publication Date Title
PL2569417T3 (pl) Izolowane populacje dorosłych komórek nerkowych i sposoby ich izolowania i stosowania
EP2526183A4 (en) Magnetic separation of rare cells
IL226156A0 (en) Modular electrochemical systems and methods
IL225635A0 (en) Supplement for cell culture
GB201119888D0 (en) Methods of receiving and receivers
EP2606123A4 (en) METHOD OF GENERATING OLIGOD DROCYTES AND CELL POPULATIONS THEREWITH
HUE053232T2 (hu) Sejtek és eljárások ramnolipidek elõállítására
PT2683815E (pt) Derivados de piridinona como inibidores da transglutaminase tecidular
ZA201207616B (en) Cell balancing system
IL214837A0 (en) Isolated populations of renal stem cells and methods of isolating and using same
EP2582910A4 (en) SYSTEMS AND METHODS FOR ISOLATING CURRENT PASSAGE TO DRILLING LOADS
IL233355A0 (en) Methods for isolating (4-chloro-2-fluoro-3-converted-phenyl)boronates and methods for using them
IL223017A0 (en) Isolated populations of adult renal cells and methods of isolating and using same
GB2496502B (en) Methods of receiving and receivers
HK40106709A (zh) 肾细胞群及其用途
GB2503761B (en) Modular interface systems and methods
HK1196395A (en) Mesenchymal stromal cell populations and methods of making same
IL221023A0 (en) Magnetic separation of rare cells
GB2492495B (en) Methods of receiving and receivers
GB201002075D0 (en) Isolation of cells
TWM389392U (en) Structural improvement of charger
HU1000558D0 (en) Separator and separation method
TWM389356U (en) Structural improvement of battery set
GB201021699D0 (en) Assay of functional cell viability
IL225348A0 (en) A method for obtaining a cell population rich in desired cells